The PEPCK inhibitor 3-MP has been shown to inhibit proliferation of lung cancer cells by targeting PEPCK-M, and a similar effect was observed in pNET cells in our study (Supplementary Figure 11). The gene discussed is PCK2; the disease is lung carcinoma.